Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan C Fuchs

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
JCI Insight|July 8, 2022
Hepatocellular carcinoma chemoprevention by targeting the angiotensin-converting enzyme and EGFR transactivationEmilie Crouchet, Shen Li, Mozhdeh Sojoodi, et al.
Gut|March 29, 2020
Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinomaFrank Jühling, Nourdine Hamdane, Emilie Crouchet, et al.
Gastroenterology|March 6, 2019
HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic ResponseNourdine Hamdane, Frank Jühling, Emilie Crouchet, et al.
Cell Metabolism|September 25, 2018
Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular CarcinomaJames S V Lally, Sarani Ghoshal, Danielle K DePeralta, et al.
Science Translational Medicine|August 21, 2020
Targeting acid ceramidase inhibits YAP/TAZ signaling to reduce fibrosis in miceSarah Alsamman, Stephanie A Christenson, Amy Yu, et al.
Cancer Cell|December 14, 2016
Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway InhibitionShigeki Nakagawa, Lan Wei, Won Min Song, et al.
Science Translational Medicine|December 21, 2022
A monoclonal antibody targeting nonjunctional claudin-1 inhibits fibrosis in patient-derived models by modulating cell plasticityNatascha Roehlen, Antonio Saviano, Houssein El Saghire, et al.
Gastroenterology|December 24, 2021
Molecular Signature Predictive of Long-Term Liver Fibrosis Progression to Inform Antifibrotic Drug DevelopmentTongqi Qian, Naoto Fujiwara, Bhuvaneswari Koneru, et al.
Nature Communications|September 18, 2021
A human liver cell-based system modeling a clinical prognostic liver signature for therapeutic discoveryEmilie Crouchet, Simonetta Bandiera, Naoto Fujiwara, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
JCI Insight|July 8, 2022
Hepatocellular carcinoma chemoprevention by targeting the angiotensin-converting enzyme and EGFR transactivationEmilie Crouchet, Shen Li, Mozhdeh Sojoodi, et al.
Gut|March 29, 2020
Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinomaFrank Jühling, Nourdine Hamdane, Emilie Crouchet, et al.
Gastroenterology|March 6, 2019
HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic ResponseNourdine Hamdane, Frank Jühling, Emilie Crouchet, et al.
Cell Metabolism|September 25, 2018
Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular CarcinomaJames S V Lally, Sarani Ghoshal, Danielle K DePeralta, et al.
Science Translational Medicine|August 21, 2020
Targeting acid ceramidase inhibits YAP/TAZ signaling to reduce fibrosis in miceSarah Alsamman, Stephanie A Christenson, Amy Yu, et al.
Cancer Cell|December 14, 2016
Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway InhibitionShigeki Nakagawa, Lan Wei, Won Min Song, et al.
Science Translational Medicine|December 21, 2022
A monoclonal antibody targeting nonjunctional claudin-1 inhibits fibrosis in patient-derived models by modulating cell plasticityNatascha Roehlen, Antonio Saviano, Houssein El Saghire, et al.
Gastroenterology|December 24, 2021
Molecular Signature Predictive of Long-Term Liver Fibrosis Progression to Inform Antifibrotic Drug DevelopmentTongqi Qian, Naoto Fujiwara, Bhuvaneswari Koneru, et al.
Nature Communications|September 18, 2021
A human liver cell-based system modeling a clinical prognostic liver signature for therapeutic discoveryEmilie Crouchet, Simonetta Bandiera, Naoto Fujiwara, et al.
Pageof 10